Company LexaGene Holdings Inc. Toronto S.E.
Equities
LXG.H
CA52886L1031
Biotechnology & Medical Research
Business Summary
Number of employees: 33
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetic Analyzer
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/07/26 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/18/01 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/20/24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/18/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/07/26 |
Tom Slezak
BRD | Director/Board Member | - | 12/16/12 |
Jane Sykes
BRD | Director/Board Member | - | 15/21/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,740,255 | 115,621,362 ( 82.15 %) | 0 | 82.15 % |
Company contact information
Lexagene Holdings, Inc.
500 Cummings Center Suite 4550
01915, Beverly
+800 215 1824
http://www.lexagene.comSector
1st Jan change | Capi. | |
---|---|---|
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M |